Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

At the 69th Annual Conference of the Israel Heart Society, UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, and Sheba Medical Center Israel revealed new research findings from a blinded pilot study that validates the company’s technology, and confirms that UltraSight’s Artificial Intelligence (AI) guidance can allow any medical professional to successfully capture quality cardiac ultrasound images.

News | Artificial Intelligence

New Study Reveals UltraSight & Sheba Medical Center Enable Novice Ultrasound Users to Obtain Accurate, Diagnostic Quality Cardiac Images

May 26, 2022 — At the 69^th Annual Conference of the Israel Heart Society, UltraSight, an Israeli-based digital health ...

May 26, 2022

Late-breaking results presented at the European Society of Cardiology's Heart Failure Association annual conference and simultaneously published online in the European Journal of Heart Failure

News | Heart Failure

Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial

May 26, 2022 — Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced ...

May 26, 2022

The study found a gene called FMNL2 links cerebrovascular disease and Alzheimer’s and suggests changes in FMNL2 activity caused by cerebrovascular disease prevent the efficient clearance of toxic proteins from the brain, eventually leading to Alzheimer’s disease.

News | Cardiovascular Clinical Studies

Missing Link Between Alzheimer's and Vascular Disease Found?

May 26, 2022 — For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol ...

May 26, 2022

Immune response and the lymphatic system are central to cardiac repair after a heart attack, according to a study from Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg Cardiovascular Research Institute.

News | Heart Failure

New Research Reveals How the Heart Repairs After a Heart Attack

May 25, 2022 — Immune response and the lymphatic system are central to cardiac repair after a heart attack, according to ...

May 25, 2022

A section of a normal healthy heart (left) and three locations in a heart from a patient with arrhythmogenic cardiomyopathy. There are a lot more fat cells (large while spheres) in the diseased heart. Cardiomyocytes in the composite region often show signs of degeneration, as well as enhanced ZBTB11 expression

News | Cardiovascular Clinical Studies

New Gene Identified in Arrhythmogenic Cardiomyopathy

May 25, 2022 — Researchers from the group of Eva van Rooij used advanced sequencing technology to better understand the ...

May 25, 2022

Continued research into efficacy of ensoETM for RF ablation procedures will support future regulatory efforts for expanded indications

News | EP Lab

First Patients Enrolled in IMPACT II Study

May 24, 2022 — Attune Medical, a pioneering medical device company with a technology platform based on temperature ...

May 24, 2022

A specific protein in blood vessel cells plays a major role in the development of vascular and cardiovascular diseases: The presence of too many "thromboxane A2 receptors" hinders the formation of new blood vessels.

News | Cardiovascular Clinical Studies

Researchers Find New Approach to Treating Cardiovascular Diseases

May 23, 2022 — A specific protein in blood vessel cells plays a major role in the development of vascular and ...

May 23, 2022

New data from a study of more than 100 million hospitalizations using machine learning augmentation was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

News | Cardio-oncology

Nationwide Study of 100 Million Hospitalizations Finds Percutaneous Coronary Intervention is Safe for Cardio-oncology Patients

May 23, 2022 — New data from a study of more than 100 million hospitalizations using machine learning augmentation was ...

May 23, 2022

Nationwide study points to implicit bias in treatment of cardiovascular disease for non-Hispanic Black patients and highlights need for equity

News | Heart Failure

Racial Disparities Seen in Treatment for Patients with Acute Coronary Syndrome and History of Cocaine Use

May 23, 2022 — Insights from a National Inpatient Sample Database examining race and the rates of cardiac ...

May 23, 2022

Findings underscore need to examine social factors that impact healthcare outcomes for most vulnerable

News | STEMI

New Study Finds Low-income Patients at Higher Risk of Death After Heart Attack

May 20, 2022 — Results from a retrospective analysis reveal significantly higher mortality rates for low-income ...

May 20, 2022

First study to compare safety and eficacy of clopidogrel and aspirin monotherapy beyond 12 months in high-risk PCI population

News | Cardiovascular Clinical Studies

Long-term Use of Clopidogrel Monotherapy Associated with Lower Patient Risk Compared to Aspirin Motherapy

May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin ...

May 20, 2022

$Multi-center study explores new treatment for heart failure patients with preserved and reduced ejection fraction$

News | Heart Failure

No-implant Interatrial Shunt Device to Treat Heart Failure Patients Reveals Promising Multi-center Clinical Data

May 20, 2022 — Results from early clinical evaluation of the Alleviant System to treat heart failure patients with ...

May 20, 2022

New Analysis Shows the Evolution of Intervention Techniques in Chronic Total Occlusion Patients

News | Chronic Total Occlusion (CTO)

International Chronic Total Occlusion Percutaneous Coronary Intervention Registry Finds Increasing Procedural Success

May 20, 2022 — A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion ...

May 20, 2022

Three years ago a study raised concerns that paclitaxel-coated devices may cause increased mortality in peripheral artery disease patients. However, numerous studies now show there is no risk of increased mortality. The most recent study is the SAFE-PAD study presented at SCAI22.

News | Peripheral Artery Disease (PAD)

New Longterm Data of Paclitaxel Devices Continues to Show No Increased Mortality Compared to Non-drug Coated Devices

May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel ...

May 20, 2022

News | Structural Heart

New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies

May 20, 2022 — Abbott announced two late-breaking data presentations highlighting both TriClip, a first-of-its kind ...

May 20, 2022